Furthermore, the ability of α3β1 to support and sustain the activation of signaling pathways upon its ligation to laminin might be necessary also during the later stages of breast cancer when cells acquire additional mutations, i.e., during the epithelial-mesenchymal transition and invasion [19, 42]. Here, LAMB2 is linked to breast cancer.